Aspartame Is a Dipeptide: What It Is and What Safety Reviews Say
Food science and peptide chemistry
Aspartame is a dipeptide: two amino acids, phenylalanine and aspartic acid, joined by a peptide bond and sold as an intense sweetener roughly 200 times sweeter than table sugar. This article explains what aspartame is chemically, what happens to it after it is swallowed, and how the major safety reviews, including the 2023 IARC and JECFA evaluations, fit together.
What is aspartame?
The FDA describes aspartame as a dipeptide composed primarily of two amino acids, phenylalanine and aspartic acid, and notes that it is about 200 times sweeter than table sugar. Chemically it is the methyl ester of the Asp-Phe dipeptide. That makes it one of the very few peptides most people consume every day without thinking of it as one. It is a useful teaching example on a peptide site because it shows that “peptide” does not automatically mean “hormone” or “drug”: a two-residue chain can be a food additive, and the same peptide-bond chemistry underlies everything from natural dipeptides such as carnosine to large therapeutic proteins.
Because the molecule is so small, its fate in the body is easy to describe. There is no receptor-binding story and no long half-life to worry about. It is broken down in the gut like any other short peptide, which is why the safety discussion centres on its breakdown products and on total intake rather than on the intact molecule.
What happens to aspartame after it is swallowed
The 2013 EFSA scientific opinion states that aspartame is rapidly and completely hydrolysed in the gastrointestinal tract to phenylalanine, aspartic acid and methanol. The first two are ordinary dietary amino acids found in all protein-containing foods. Methanol is a small alcohol, and it is the breakdown product that is most often discussed.
For most people the practical consequence is that aspartame contributes amino acids and a small amount of methanol to the diet, and the regulatory acceptable daily intake is set with those products in mind. EFSA’s 2013 opinion reported that current exposures to aspartame and to its degradation product diketopiperazine (DKP) were below their respective acceptable daily intakes. For a related discussion of how peptides break down generally, see our guide to peptide degradation.
Aspartame and phenylketonuria (PKU)
Phenylketonuria is a genetic disorder of phenylalanine metabolism. Because aspartame releases phenylalanine, the FDA advises that people with PKU should avoid or restrict it, and product labels must state that the product contains phenylalanine. The EFSA panel went further: it stated that the acceptable daily intake is not applicable to PKU patients. For people without PKU, and for PKU heterozygotes, EFSA concluded that aspartame at the acceptable daily intake, added to dietary phenylalanine, would not push peak plasma phenylalanine above the clinical guideline for protecting fetuses.
How much aspartame is acceptable? The ADI explained
The acceptable daily intake (ADI) is the amount that can be consumed daily over a lifetime without appreciable health risk, expressed per kilogram of body weight. JECFA and EFSA both use 40 mg/kg of body weight per day for aspartame, while the FDA lists 50 mg/kg per day. WHO illustrates the JECFA figure by noting that an adult weighing 70 kg would need to consume more than 9 to 14 cans per day of diet soft drink (assuming 200 to 300 mg of aspartame per can) to exceed it, assuming no other dietary sources. That is a simple division, and it is worth keeping in mind when headlines suggest that ordinary use is close to the limit.
What the 2023 aspartame evaluations actually said
In July 2023 two separate bodies reported on aspartame at the same time, which caused confusion. IARC, the International Agency for Research on Cancer, classified aspartame as possibly carcinogenic to humans (Group 2B). WHO explains that Group 2B is the third-highest of four levels and is used when evidence of cancer in humans is limited but not convincing, or when evidence in animals is convincing but human evidence is not. IARC cited limited evidence for hepatocellular (liver) carcinoma in humans, plus limited evidence in animals and on mechanisms. JECFA, the joint FAO/WHO expert committee on food additives, reviewed the same question from a risk perspective and found no sufficient reason to change the previously established ADI, stating that the evidence of an association with cancer in humans is not convincing.
Aspartame compared with other peptide-based additives and drugs
Aspartame sits at the opposite end of the peptide spectrum from therapeutic peptides. It is a dipeptide that is digested, not absorbed intact, and it has no dosing protocol. Therapeutic peptides, by contrast, are designed to survive long enough to act, which is why they typically need chemical modifications or injection; our overview of peptides versus small-molecule drugs covers that difference, and the guide to reading peptide sequences explains the three-letter codes used above (Asp, Phe). Researchers who handle lyophilized peptides can use the reconstitution calculator for concentration arithmetic; it is not relevant to food use.
Frequently asked questions about aspartame
Is aspartame a peptide?
Yes, in the chemical sense. It is a dipeptide methyl ester built from phenylalanine and aspartic acid. It is a food additive, not a hormone or a drug.
Why does the label mention phenylalanine?
Because the molecule releases phenylalanine when digested, and people with phenylketonuria cannot process that amino acid normally. FDA requires the statement on products containing aspartame.
Did IARC say aspartame causes cancer?
No. IARC placed it in Group 2B, “possibly carcinogenic to humans”, on the basis of limited evidence. Its classification describes the strength of evidence for a hazard, not the risk at a particular intake.
Why do the ADI figures differ between agencies?
JECFA and EFSA use 40 mg/kg per day; the FDA lists 50 mg/kg per day. The sources reviewed here do not explain the difference, so we report both figures as published.
References
- World Health Organization. Aspartame hazard and risk assessment results released (14 July 2023).
- U.S. Food and Drug Administration. Aspartame and Other Sweeteners in Food.
- EFSA Panel on Food Additives and Nutrient Sources. Scientific Opinion on the re-evaluation of aspartame (E 951) as a food additive. EFSA Journal 2013.
- Magnuson BA et al. Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Crit Rev Toxicol 2007.
Informational only — not medical advice. This article is for educational purposes. It does not recommend, sell or instruct personal human use of any compound. Consult a qualified healthcare professional for any health decision. Content is intended for adults 21+. Verify scientific details against the primary sources cited.